Key facts
- Liposphere’s last known valuation is $65.1M (Apr 2022).
- It has raised $8.8M; the latest was Later Stage VC in Jan 2025.
- Notable investors include MassChallenge, Capmont, DIVEdigital, Daniel Gamsu, Weizmann Institute of Science.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Liposphere
- ·The full record, as it builds
Funding rounds
No funding rounds for Liposphere are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Liposphere
Developer of a knee joint articulation injectable designed to deliver ultra-low friction and efficient lubrication. The company specializes in using hydration water as the lubricating element, which spontaneously adsorbs and coats the knee joints' cartilage surface, orthopedic implants, and contact lenses, enabling healthcare professionals and manufacturers to reduce wear and tear caused by friction.
- Sector
- Healthcare
- HQ
- Givat-Shmuel, Israel
- Founded
- 2019
- Employees
- 30
- Website
- lipo-sphere.com/
- Ownership
- Privately Held (backing)
Liposphere doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Liposphere shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Liposphere in its N-PORT filings yet. We sweep new filings monthly.